Baxter to sell its kidney-care business in a $3.8 billion deal to Carlyle Group

By / / Finance / 1 minute of reading



im 40472550
Shares of Baxter International Inc. gained ground early Tuesday, after the healthcare-products company announced an agreement to sell its kidney-care business — to be named Vantive — to private-equity investor Carlyle Group Inc. in a deal valued at $3.8 billion.



Source link

About The Author

Avatar of Shana Hull
Shana Hull is a professional writer, editor, and interviewer. She's written for a variety of publications in the arts, construction, automotive, travel, real estate, and fashion industries. Shana has also worked as a content strategist for several companies in the finance and technology sectors.

Start typing and press enter to search

Scroll to Top